Leerink Partners analyst Joseph Schwartz has reiterated their bullish stance on LRMR stock, giving a Buy rating on January 24.Invest with ...
Microsoft Corporation, Apple Inc, Tesla Inc, Meta Platforms Inc. Read Investing.com (David Wagner)'s latest article on ...
JMP Securities analyst Silvan Tuerkcan maintained a Buy rating on Relay Therapeutics (RLAY – Research Report) today and set a price target of ...
Alnylam Pharmaceuticals (NASDAQ:ALNY), with a market capitalization of $35.4 billion, has emerged as a leading player in the RNA interference (RNAi) therapeutics space, with a particular focus on ...
Amgen Inc . (NASDAQ:AMGN), a leading biotechnology company with a market capitalization of $151.3 billion, is navigating a ...
The Swiss government's 2024 accounts, forecast to show a deficit of CH 2.6 billion ($2.8 billion), should be better than ...
Fitch Ratings - London: Fitch Ratings has affirmed Saudi Arabia's Long-Term Foreign-Currency Issuer Default Rating (IDR) at 'A+' with a Stable Outlook. A full list of rating actions is at the end of ...
TSMC to increase capex by 34%, driven by AI spends and N2 node ramp. Peak margins expected, but structural improvements may offset. Read more here.
F5, Inc.'s Q1 results showed strong revenue and margin performance, with notable competitive wins. Read why I remain bullish ...
DelveInsight's Peptide-drug Conjugate Market Insights report provides the current and forecast market analysis, individual ...
LONDON/TOKYO (Reuters) -The euro zone's beleaguered manufacturing industry showed some signs of stabilisation last month but ...